ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Acurx Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.14+0.04 (+3.64%)
Close on Oct 19, 2026
- Market cap
- $4.86M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
2.4%
0M of 5M shares
Institutional holders
19
2 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ACXP | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 31,099 | 0.59% | $48.20K | – | 0.00% |
| Geode Capital Management, LLC | 26,411 | 0.50% | $40.94K | +1,592 | 0.00% |
| Vanguard Fiduciary Trust Co | 16,205 | 0.31% | $25.12K | – | 0.00% |
| Jane Street Group, LLC | 15,727 | 0.30% | $24.38K | −38,915 | 0.00% |
| Prospect Financial Services LLC | 13,785 | 0.26% | $21.37K | – | 0.01% |
| Morgan Stanley | 7,500 | 0.14% | $11.63K | +1,000 | 0.00% |
| Integrated Wealth Concepts LLC | 4,729 | 0.09% | $7.33K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 2,744 | 0.05% | $4.25K | +1,713 | 0.00% |
| Wells Fargo & Company/Mn | 2,300 | 0.04% | $3.57K | – | 0.00% |
| Westside Investment Management, Inc. | 1,650 | 0.03% | $2.56K | – | 0.00% |
| Nbc Securities, Inc. | 1,500 | 0.03% | $2.33K | – | 0.00% |
| Barclays PLC | 281 | 0.01% | $436 | −99 | 0.00% |
| Cornerstone Planning Group LLC | 167 | 0.00% | $245 | – | 0.00% |
| Osaic Holdings, Inc. | 100 | 0.00% | $155 | – | 0.00% |
| Group One Trading, L.P. | 95 | 0.00% | $147 | −150 | 0.00% |
| BlackRock, Inc. | 60 | 0.00% | $93 | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 23 | 0.00% | $36 | New | 0.00% |
| SBI Securities Co., Ltd. | 6 | 0.00% | $9 | – | 0.00% |
| UBS Group AG | 3 | 0.00% | $5 | −6,309 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 19 | 0M | 2.4% | 2 / 3 | 4 / 4 | 0M | 0M |
| Q1 2026 | 21 | 0M | 3.5% | 7 / 3 | 4 / 3 | 0M | 0M |
| Q4 2025 | 18 | 0M | 2.6% | 7 / 3 | 5 / 5 | 0M | 0M |
| Q3 2025 | 16 | 0M | 1.1% | 15 / 1 | 0 / 0 | 0M | 0M |
| Q2 2025 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ACXP | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 31,099 | 0.59% | $48.20K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 16,250 | 0.31% | $32.18K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 2,978 | 0.06% | $5.90K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,001 | 0.02% | $1.98K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 146 | 0.00% | $289 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| David P. Luci | President and CEO, Director | 1,147,541 | 21.78% | Apr 22, 2026 |
| Robert G. Shawah | Chief Financial Officer | 189,200 | 3.59% | Apr 22, 2026 |
| Carl Sailer | Director | 142,183 | 2.70% | Apr 22, 2026 |
| Jack H. Dean | Director | 27,546 | 0.52% | Apr 22, 2026 |
| James J. Donohue | Director | 22,352 | 0.42% | Apr 22, 2026 |
| Thomas L. Harrison | Director | 1,539 | 0.03% | Apr 22, 2026 |
| Robert J. Deluccia | Director | 1,014,043 | 19.24% | Apr 22, 2026 |
| Joseph C. Scodari | Director | 27,708 | 0.53% | Apr 22, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Carl Sailer Director | Jan 6, 2025 | Buy | +24,631 | $1.02 | $25.12K | 137,183 |
| Joseph C. Scodari Director | Jan 6, 2025 | Buy | +24,631 | $1.02 | $25.12K | 27,708 |
| Robert J. Deluccia Director, 10% owner | Jan 6, 2025 | Buy | +49,261 | $1.02 | $50.25K | 1,010,196 |
| Jack H. Dean Director | Jan 6, 2025 | Buy | +9,852 | $1.02 | $10.05K | 21,776 |
| James J. Donohue Director | Jan 6, 2025 | Buy | +9,852 | $1.02 | $10.05K | 22,352 |
| David P. Luci President and CEO, Director, 10% owner | Jan 6, 2025 | Buy | +49,261 | $1.02 | $50.25K | 1,097,458 |
| Carl Sailer Director | Jan 19, 2024 | Option exercise | +19,737 | $3.55 | $70.07K | 112,552 |
| David P. Luci President and CEO, Director, 10% owner | Jan 3, 2024 | Option exercise | +19,737 | $3.55 | $70.07K | 1,048,197 |
| Robert J. Deluccia Director, 10% owner | Jan 3, 2024 | Option exercise | +19,737 | $3.55 | $70.07K | 960,935 |
| Robert J. Deluccia Director, 10% owner | Dec 22, 2023 | Gift | −30,000 | – | – | 941,198 |
| Robert J. Deluccia Director, 10% owner | Dec 12, 2023 | Gift | −40,000 | – | – | 971,198 |
| Robert J. Deluccia Director, 10% owner | Jul 27, 2022 | Buy | +19,737 | $3.80 | $75.00K | 1,051,198 |
| David P. Luci President and CEO, Director, 10% owner | Jul 27, 2022 | Buy | +19,737 | $3.80 | $75.00K | 1,028,460 |
| Carl Sailer Director | Jul 27, 2022 | Buy | +19,737 | $3.80 | $75.00K | 92,815 |
| Robert J. Deluccia Director, 10% owner | Dec 2, 2021 | Gift | −40,000 | – | – | 1,011,198 |
| Carl Sailer Director | Nov 23, 2021 | Buy | +5,161 | $4.84 | $24.98K | 73,078 |
| Robert J. Deluccia Director, 10% owner | Nov 19, 2021 | Buy | +5,034 | $4.90 | $24.67K | 1,031,461 |
| David P. Luci President and CEO, Director, 10% owner | Nov 19, 2021 | Buy | +5,200 | $4.80 | $24.96K | 1,008,723 |
| Carl Sailer Director | Jun 29, 2021 | Buy | +12,500 | $6.00 | $75.00K | 67,917 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.